Actinoplanes utahensis
Jump to navigation
Jump to search
| Actinoplanes utahensis | |
|---|---|
.jpg)
| |
Scientific classification 
| |
| Domain: | Bacteria |
| Phylum: | Actinomycetota |
| Class: | Actinomycetia |
| Order: | Micromonosporales |
| Family: | Micromonosporaceae |
| Genus: | Actinoplanes |
| Species: | A. utahensis
|
| Binomial name | |
| Actinoplanes utahensis Couch 1963 (Approved Lists 1980)[1]
| |
| Type strain | |
| ATCC 14539 DSM 43147 IFO 13244 JCM 3122 NBRC 13244 NRRL B-16727 VKM Ac-674 | |
Actinoplanes utahensis is a species of bacteria and a source of the drug acarbose, an alpha-glucosidase inhibitor used in the treatment of diabetes mellitus.
Description
A. utahensis are irregular in size and shape. They form sporangia which are 5 to 18 micrometers in diameter, and contain spores arranged in irregular coils. A. utahensis are motile by way of a number of flagella at one end.[2]
History
A. utahensis was originally identified by John Couch from soils collected from Salt Lake City's Liberty Park as well as along U.S. Route 40 in Nevada.[1]
References
- ^ a b "Some New Genera and Species of the Actinoplanaceae". Journal of the Elisha Mitchell Scientific Society. 79: 69. May 1963. Retrieved 15 October 2017.
- ^ Vobis G, Schafer J, Kampfer P (14 September 2015). "Actinoplanes". In Whitman WB (ed.). Bergey's Manual of Systematics of Archaea and Bacteria. John Wiley & Sons. pp. 1–41. doi:10.1002/9781118960608.gbm00139. ISBN 9781118960608.